🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/06/1985 | 0,0212 USD |
| 28/02/1985 | 0,0212 USD |
| 03/12/1984 | 0,0212 USD |
| 31/08/1984 | 0,0199 USD |
| 29/05/1984 | 0,0199 USD |
| 01/03/1984 | 0,0199 USD |
| 29/11/1983 | 0,0199 USD |
| 29/08/1983 | 0,0186 USD |
| 31/05/1983 | 0,0186 USD |
| 28/02/1983 | 0,0186 USD |
| 30/11/1982 | 0,0186 USD |
| 30/08/1982 | 0,0186 USD |
| 01/06/1982 | 0,0186 USD |
| 01/03/1982 | 0,0186 USD |
| 01/12/1981 | 0,0186 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 08/01/1987 | 6,80 | 6,88 | 6,74 | 6,87 | +1,27% | 2,05% | 17.103.989 |
| 07/01/1987 | 6,71 | 6,79 | 6,68 | 6,79 | +0,39% | 1,58% | 13.627.354 |
| 06/01/1987 | 6,84 | 6,85 | 6,76 | 6,76 | -0,97% | 1,36% | 14.964.811 |
| 05/01/1987 | 6,84 | 6,84 | 6,76 | 6,83 | +2,18% | 1,16% | 12.091.824 |
| 02/01/1987 | 6,58 | 6,68 | 6,47 | 6,68 | +1,72% | 3,22% | 15.147.792 |
| 31/12/1986 | 6,69 | 6,71 | 6,55 | 6,57 | -1,78% | 2,38% | 8.488.800 |
| 30/12/1986 | 6,65 | 6,72 | 6,60 | 6,69 | +0,90% | 1,79% | 9.963.965 |
| 29/12/1986 | 6,73 | 6,75 | 6,60 | 6,63 | -3,47% | 2,17% | 13.746.197 |
| 26/12/1986 | 6,56 | 6,86 | 6,55 | 6,86 | +5,07% | 4,85% | 8.852.875 |
| 24/12/1986 | 6,35 | 6,57 | 6,35 | 6,53 | +2,92% | 3,44% | 9.216.950 |
| 23/12/1986 | 6,31 | 6,39 | 6,28 | 6,35 | +1,59% | 1,68% | 15.706.166 |
| 22/12/1986 | 6,18 | 6,30 | 6,16 | 6,25 | +0,86% | 2,14% | 27.352.800 |
| 19/12/1986 | 6,03 | 6,20 | 6,00 | 6,20 | +3,43% | 3,19% | 50.932.800 |
| 18/12/1986 | 6,04 | 6,04 | 5,97 | 5,99 | -0,11% | 1,10% | 7.057.022 |
| 17/12/1986 | 6,04 | 6,06 | 5,97 | 6,00 | -1,09% | 1,53% | 8.124.725 |
| 16/12/1986 | 6,02 | 6,10 | 6,00 | 6,06 | +1,22% | 1,54% | 11.791.886 |
| 15/12/1986 | 5,92 | 5,99 | 5,84 | 5,99 | +0,89% | 2,57% | 8.441.640 |
| 12/12/1986 | 5,98 | 6,00 | 5,94 | 5,94 | -1,00% | 1,11% | 4.159.512 |
| 11/12/1986 | 6,11 | 6,11 | 5,91 | 6,00 | -1,84% | 3,25% | 7.275.845 |
| 10/12/1986 | 6,05 | 6,14 | 6,04 | 6,11 | +1,10% | 1,53% | 5.234.760 |
| 09/12/1986 | 6,04 | 6,08 | 6,02 | 6,04 | -0,22% | 0,99% | 3.640.752 |
| 08/12/1986 | 6,06 | 6,10 | 5,96 | 6,06 | +0,00% | 2,19% | 7.475.803 |
| 05/12/1986 | 6,10 | 6,11 | 5,94 | 6,06 | -0,44% | 2,83% | 9.794.189 |
| 04/12/1986 | 6,04 | 6,12 | 6,02 | 6,08 | +0,66% | 1,75% | 7.034.386 |
| 03/12/1986 | 5,99 | 6,11 | 5,99 | 6,04 | -0,87% | 1,99% | 10.737.389 |
| 02/12/1986 | 5,92 | 6,12 | 5,91 | 6,10 | +3,84% | 3,47% | 20.373.120 |
| 01/12/1986 | 5,83 | 5,87 | 5,76 | 5,87 | +0,23% | 1,82% | 5.749.747 |
| 28/11/1986 | 5,88 | 5,90 | 5,84 | 5,86 | -0,23% | 0,90% | 2.561.731 |
| 26/11/1986 | 5,85 | 5,88 | 5,84 | 5,87 | +0,00% | 0,68% | 3.433.248 |
| 25/11/1986 | 5,88 | 5,88 | 5,82 | 5,87 | +0,45% | 1,13% | 4.819.752 |